SPI Pharma specializes in innovative solutions for the pharmaceutical and nutritional industries, focusing on excipients, antacid actives, and drug delivery systems. They are leaders in developing ingredients for oral dosage forms such as chewable tablets, effervescents, and taste-masking technologies. With a portfolio that includes industry-leading platforms like UltraBurst™ for fast-disintegrating tablets, SPI Pharma addresses complex formulation challenges while improving patient outcomes. Their global presence and technical expertise make them a trusted partner for efficient, cost-effective solutions.
Visit Company Website
